Literature DB >> 15513970

Irish injecting drug users and hepatitis C: the importance of the social context of injecting.

Bobby P Smyth1, Joe Barry, Eamon Keenan.   

Abstract

BACKGROUND: The incidence of hepatitis C (HCV) infection among injecting drug users (IDUs) in Dublin is particularly high by international standards. The most robust predictor of an IDU's HCV status is his or her total number of lifetime injecting episodes. It has been proposed that participation in specific unsafe injecting practices is the principal contributor to this accumulated risk. We sought to test this hypothesis. The relationship between social context of injecting and HCV status was also examined.
METHODS: We conducted a cross-sectional survey of IDUs recruited from treatment settings in Dublin. Participants had injected in the preceding six months and had not previously been tested for HCV. A structured interview was conducted.
RESULTS: HCV testing was performed on 159 IDUs, and 61% were antibody positive. The three characteristics that were significant independent predictors of a positive test result were increased total number of lifetime injecting episodes, closer social relationships with other IDUs, and injecting in the home of other IDUs. Frequency of recipient syringe sharing (i.e. borrowing used syringes from other IDUs), backloading, and sharing of injecting paraphernalia were not independently associated with infection.
CONCLUSIONS: We found that the robust association between HCV infection and number of lifetime injecting episodes was not explained by increased unsafe injecting practices. The socialized nature of heroin injecting in Dublin is contributing to the HCV epidemic in this population. Our findings suggest that accidental and unnoticed sharing of injecting equipment may be an important contributor to an IDU's increasing risk of infection over time.

Entities:  

Mesh:

Year:  2004        PMID: 15513970     DOI: 10.1093/ije/dyh347

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  11 in total

Review 1.  Opioids and HIV/HCV infection.

Authors:  Xu Wang; Ting Zhang; Wen-Zhe Ho
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-14       Impact factor: 4.147

2.  Morphine withdrawal enhances hepatitis C virus replicon expression.

Authors:  Chuan-Qing Wang; Yuan Li; Steven D Douglas; Xu Wang; David S Metzger; Ting Zhang; Wen-Zhe Ho
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

3.  Exploring Patient Characteristics and Barriers to Hepatitis C Treatment in Patients on Opioid Substitution Treatment Attending a Community Based Fibro-scanning Clinic.

Authors:  Des Crowley; Walter Cullen; Eamon Laird; John S Lambert; Tina Mc Hugh; Carol Murphy; Marie Claire Van Hout
Journal:  J Transl Int Med       Date:  2017-06-30

4.  Upregulation of SOCS-3 and PIAS-3 impairs IL-12-mediated interferon-gamma response in CD56 T cells in HCV-infected heroin users.

Authors:  Li Ye; Xu Wang; David S Metzger; Eric Riedel; Luis J Montaner; Wenzhe Ho
Journal:  PLoS One       Date:  2010-03-09       Impact factor: 3.240

5.  Methamphetamine enhances Hepatitis C virus replication in human hepatocytes.

Authors:  L Ye; J S Peng; X Wang; Y J Wang; G X Luo; W Z Ho
Journal:  J Viral Hepat       Date:  2008-04       Impact factor: 3.728

Review 6.  A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groups.

Authors:  Corina Lelutiu-Weinberger; Enrique R Pouget; Don D C Des Jarlais; Hannah L Cooper; Roberta Scheinmann; Rebecca Stern; Shiela M Strauss; Holly Hagan
Journal:  Soc Sci Med       Date:  2008-12-04       Impact factor: 4.634

7.  Quantifying hepatitis C transmission risk using a new weighted scoring system for the Blood-Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ): applications for community-based HCV surveillance, education and prevention.

Authors:  Mark A Stoové; Craig L Fry; Nicholas Lintzeris
Journal:  Harm Reduct J       Date:  2008-04-23

8.  Positive deviance control-case life history: a method to develop grounded hypotheses about successful long-term avoidance of infection.

Authors:  Samuel R Friedman; Pedro Mateu-Gelabert; Milagros Sandoval; Holly Hagan; Don C Des Jarlais
Journal:  BMC Public Health       Date:  2008-03-20       Impact factor: 3.295

Review 9.  Impact of methamphetamine on infection and immunity.

Authors:  Sergio A Salamanca; Edra E Sorrentino; Joshua D Nosanchuk; Luis R Martinez
Journal:  Front Neurosci       Date:  2015-01-12       Impact factor: 4.677

10.  Hepatitis C virus seroprevalence and prevalence of chronic infection in the adult population in Ireland: a study of residual sera, April 2014 to February 2016.

Authors:  Patricia Garvey; Brian O'Grady; Geraldine Franzoni; Maeve Bolger; Katie Irwin Crosby; Jeff Connell; Deirdre Burke; Cillian De Gascun; Lelia Thornton
Journal:  Euro Surveill       Date:  2017-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.